Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
Year: 2013
Type: review
Source: Clinical Research in Cardiology
Institutions: Klinikum Frankfurt Höchst, Universitätsklinikum des Saarlandes, Ludwig-Maximilians-Universität München, Essen University Hospital, Center for Stroke Research Berlin, Charité – Universitätsmedizin Berlin, University Hospital Bonn, Asklepios Klinik Altona, Johannes Wesling Klinikum Minden, LMU Klinikum, Heidelberg University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: direct oral anticoagulants, apixaban, dabigatran, rivaroxaban, emergency management, thrombolysis, acute ischemic stroke, intracranial hemorrhage, gastrointestinal bleeding, renal dysfunction, drug accumulation, anticoagulant reversal, anti-Xa activity, prothrombin complex concentrate, antifibrinolytic agents, atrial fibrillation, stroke prevention
Open Access status: closed
OpenAlex ID: W2046188252
